Chloramphenicol: Nursing pharmacology

Chloramphenicol: Nursing pharmacology

5106

5106

Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Insulin: Nursing pharmacology
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Laxatives: Nursing pharmacology
Pharmacodynamics: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Chloramphenicol: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Angiogenesis inhibitors: Nursing pharmacology
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology

Notes

CHROLAMPHENICOL
DRUG NAME
chloramphenicol 
CLASS
Miscellaneous protein synthesis inhibitor
MECHANISM OF ACTION
Binds to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and preventing bacterial growth
INDICATIONS
Alternative treatment of bacterial meningitis, typhus, and Rocky Mountain spotted fever (rarely used due to severe toxicity)
ROUTE(S) OF ADMINISTRATION
IV
SIDE EFFECTS
  • Nausea, vomiting, and diarrhea 
  • Neurotoxicity 
  • Metabolic acidosis 
  • Blood dyscrasias 
  • Infants: gray syndrome 
CONTRA-
INDICATIONS AND CAUTIONS
  • Pregnancy, breastfeeding, newborns 
  • G6PD deficiency, acute porphyria 
  • Inhibitor of the cytochrome p450 family: toxicity (e.g., warfarin, sulfonylureas, phenytoin) 
  • Decreases the effect of ceftazidime, estriol, and vitamin B12 
NURSING CONSIDERATIONS
Assessment and monitoring 
Assessment
  • Vital signs; especially temperature 
  • Current symptoms: headaches, stiff neck, confusion, light sensitivity 
  • Laboratory test results: renal and liver function, CBC, blood cultures 
  • Diagnostic results: cerebral spinal fluid analysis

Administration
  • Patient IV 
  • Calculate the dose in mg/kg/day 
  • Administer prescribed vitamin B12 supplement 

Monitoring
  • CBC and serum drug concentration 
  • Insertion site 
  • Side effects 
    • Neurotoxicity 
    • Superinfection 
    • Bone marrow suppression 
  • Evaluate: infection resolution and absence of symptoms 

Client education 
  • Purpose of medication: to treat the infection causing their symptoms 
  • Administered IV every six hours 
  • Side effects 
    • Nausea, vomiting, diarrhea 
    • Report: extremity numbness, tingling or visual changes 

Author: Anna Hernández, MD
Author: Mary Roberts, MSN, RN
Illustrator: Patricia Nguyen, MScBMC

Transcript

Watch video only

Chloramphenicol is a broad spectrum antibiotic that is active against both gram-positive and gram-negative bacteria.

However, due to its severe toxicity, chloramphenicol is no longer used as the first medication of choice in most countries with access to safer antibiotics; instead, this medication is typically used when other antibiotics are ineffective or contraindicated.

Nowadays, chloramphenicol is most often used intravenously, and since it readily crosses the blood-brain barrier, it may be used to treat bacterial meningitis in clients who have major hypersensitivity reactions to penicillin.

Additionally, it can be considered for the treatment of serious rickettsial infections, such as typhus and Rocky Mountain spotted fever.

Once administered, chloramphenicol has a bacteriostatic effect by reversibly binding to the 50S subunit of the bacterial ribosome, thereby inhibiting bacterial protein synthesis, and ultimately stopping bacterial growth.

Now, chloramphenicol may cause side effects like gastrointestinal disturbances, such as nausea, vomiting, and diarrhea.

Additionally, it has a boxed warning for blood dyscrasia, including fatal aplastic anemia, hypoplastic anemia, and bone marrow suppression, and it can increase the risk of developing superinfections.

Other side effects of chloramphenicol include severe metabolic acidosis; as well as neurotoxicity, which can manifest as optic neuritis or peripheral neuropathy.

Finally, infants lack a hepatic enzyme involved in the metabolism of chloramphenicol, so the medication may accumulate in their body until it reaches toxic levels.

As a result, administering chloramphenicol to infants can lead to gray syndrome, which presents with anemia and cyanosis.

In severe cases, there may also be vomiting, hypothermia, limp body, cardiovascular collapse, and eventually death if not treated promptly.

Now, as far as contraindications go, chloramphenicol is not recommended for use during pregnancy, breastfeeding, or in newborns.

In addition, chloramphenicol should be used with caution in clients with glucose-6-phosphate dehydrogenase or G6PD deficiency, as well as in clients with acute porphyria, since this medication could increase the risk of developing an acute porphyria attack.

Regarding interactions, chloramphenicol is also a weak inhibitor of the hepatic enzymes in the cytochrome P450 family, so it can interfere with the metabolism of certain medications, including warfarin, sulfonylureas, and phenytoin, which may reach toxic levels. In addition, chloramphenicol can decrease the effect of ceftazidime, estriol, and vitamin B12.

Okay, when caring for a client prescribed intravenous chloramphenicol for bacterial meningitis, start by performing a baseline assessment including vital signs, and current symptoms like headaches, stiff neck, confusion, and light sensitivity.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Sensitivity Pattern Of Salmonella typhi And Paratyphi A Isolates To Chloramphenicol and Other Anti-Typhoid Drugs: An In Vitro Study" Infect Drug Resist (2019)
  6. "Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota" Microorganisms (2019)
  7. "Recent Trends in Synthesis of Chloramphenicol New Derivatives" Antibiotics (2021)